The PARP Inhibitors Market is witnessing remarkable momentum, fueled by significant strides in cancer therapeutics and growing research in precision medicine. These small molecule drugs, which block the poly (ADP-ribose) polymerase enzyme, have shown proven efficacy in treating cancers with...